![Shire considers bid for NPS: Report](https://www.benefitscanada.com/wp-content/uploads/sites/7/2010/12/news-paper-headline.jpg)
Shire is reportedly looking at buying U.S.-based NPS Pharmaceuticals.
The news comes just a couple of months after AbbVie dropped its takeover offer for Shire.
Shire received a US$1.64-billion breakup fee after that deal collapsed.
NPS Pharmaceuticals’ current therapeutic areas of focus are gastrointestinal disease and endocrine disorders.
For the full story, visit the Bloomberg News website.
Read: